InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hoffmann Bernhard. Officer active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 5 reports have been recorded. Activity tracked since 10 January 2023. The latest transaction was disclosed on 13 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations